Hugel smooths out wrin­kles with FDA, wins ap­proval for Botox com­peti­tor

Last year
Pharma
FDA+

San­doz com­pletes $170M buy of Lu­cen­tis biosim­i­lar from Co­herus Bio­Sciences

Last year
Deals
Pharma

Pfiz­er to 'wind down con­struc­tion' of Seagen's $350M man­u­fac­tur­ing site

Last year
Manufacturing

Q&A: Sanofi’s CEO on the con­sumer di­vesti­ture, a fu­ture in weight loss, an­titrust and AI’s se­cre­cy wave

Last year
Pharma

Drug­mak­ers sub­mit coun­terof­fers as part of first round of drug price ne­go­ti­a­tions

Last year
Law

Cor­rect­ed: Mer­ck KGaA bags an­oth­er pro­tein de­grad­er deal for $16M up­front, this time with C4

Last year
Deals
R&D

FDA push­es back de­ci­sion on Zevra’s drug; Re­vance to raise $100M

Last year
News Briefing

Who’s paving the way for LGBTQ+ lead­ers in bio­phar­ma? Nom­i­nate them for End­points’ an­nu­al re­port

Last year
People

Cor­morant nears the close of fifth pri­vate health­care fund as biotech in­dus­try sees green­er pas­tures

Last year
Financing

Al­ly Bridge beefs up 'new gen­er­a­tion' as in­vest­ment firm pass­es 10-year mark

Last year
People
Financing

Ex­clu­sive: No­cion rais­es $62M for dif­fer­ent ap­proach to chron­ic cough than Mer­ck, GSK

Last year
Financing
Startups

Akero re­turns with more MASH da­ta to back PhI­II drug, touts fi­bro­sis re­sponse rate

Last year
R&D

Bay­er buys Eu­ro­pean rights to Bridge­Bio's AT­TR-CM pill

Last year
Deals
Pharma

Eli Lil­ly’s Alzheimer’s trek; No­vo Nordisk puts down US roots; Sarep­ta and gene ther­a­py ac­cel­er­at­ed ap­provals; ...

Last year
Weekly

J&J's Janssen nabs new in­di­ca­tion, full ap­proval for can­cer drug Ry­bre­vant

Last year
R&D
FDA+

FDA di­rects spon­sors to keep in­formed con­sent in­fo con­cise, tai­lored to par­tic­i­pants

Last year
FDA+

En­do inks $465M bank­rupt­cy deal set­tling crim­i­nal and civ­il opi­oid cas­es

Last year
Pharma
Law

Ar­rakis Ther­a­peu­tics re­duces head­count by 20%

Last year
People
Startups

Pfiz­er lays out am­bi­tious vi­sion for can­cer port­fo­lio in bid to rein­vig­o­rate its busi­ness

Last year
R&D

GAO di­rects ARPA-H to fi­nal­ize plan for han­dling du­pli­cate re­search

Last year
R&D
Pharma

ACIP rec­om­mends ex­pand­ed use for Val­neva's chikun­gun­ya vac­cine and Covid boost­ers

Last year
Pharma

In­smed en­cour­ages peo­ple to 'S­peak Up' in new mar­ket­ing ef­fort

Last year
Pharma
Marketing

UK re­lies on EMA's re­view of Xge­va re­for­mu­la­tion in first-ever rec­i­p­ro­cal ap­proval

Last year
Pharma

Judge rules against As­traZeneca in suit over IRA price ne­go­ti­a­tions

Last year
Pharma
Law
First page Previous page 191192193194195196197 Next page Last page
A service from the Financial Times